Company News: Page (1) of 1 - 05/31/14

PROCLAIM(SM) National Patient Registry Analysis Shows Improved Median Overall Survival in Patients with Metastatic Melanoma Treated with High-Dose Interleukin-2 (HD IL-2)

Data Support Adoption of Stable Disease as Response Criterion, Raise Intriguing Hypotheses about Sequential Therapy and Utility of IL-2 as Salvage Option

May 31, 2014 --
This article is no longer available,but here are some related topics.

Page: 1
Related Keywords:Pro AV,Post/Production,Presentors,Director,Business,Marketing,Standards/Initiatives,OS (Operating System), Inc.,Medicine,Disease,healthcare,Cancer,Surgery,Medication,Vitamins/Nutrition,Physician,Science,Lifestyle,Medical,Biology,Cancer,Business,Science,Adults,

Source:PR Newswire. All Rights Reserved

Our Privacy Policy --- @ Copyright, 2015 Digital Media Online, All Rights Reserved

Webmaster
Digital Media Online, Inc.